Clopidogrel Bisulfate

Catalog No.S1415 Synonyms: SR-25990C

Clopidogrel Bisulfate Chemical Structure

Molecular Weight(MW): 419.9

Clopidogrel is an oral, thienopyridine class antiplatelet agent.

Size Price Stock Quantity  
USD 70 In stock
USD 170 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Cited by 2 Publications

2 Customer Reviews

  • (A) HPLC glycan traces of IgG recovered from joint after K/BxN and PBS or B4ST6Fc treatment with or without clopidogrel. (B) Ratios of monosialylated and agalactosylated glycans (S1/G0) from IgG described in (A).

    Cell, 2018, 172(3):564-577.e13. Clopidogrel Bisulfate purchased from Selleck.

    C, The expression of EGFR in the clopidogrel‐ treated cells was analyzed by immunoblot analysis. The clopidogrel‐treated cells (HSC3 and SAS) show down‐regulation of FBLIM1 and EGFR compared with the control cells. D, The images of expression of EGFR after treatment with clopidogrel for 48 h analyzed by IF. Most EGFR is localized at the cellular membrane; in contrast, treatment with clopidogrel caused internalization of EGFR. Clop, clopidogrel.

    Mol Carcinog, 2018, 57(12):1690-1697. Clopidogrel Bisulfate purchased from Selleck.

Purity & Quality Control

Choose Selective P2 Receptor Inhibitors

Biological Activity

Description Clopidogrel is an oral, thienopyridine class antiplatelet agent.
Targets
P2Y12 [1]
In vitro

Clopidogrel is converted to its active metabolite by cytochrome P450 (CYP) enzymes. [1] Clopidogrel (1 μM) also inhibits EGF-stimulated EGF receptor, PERK expression, and cell proliferation in RGM-1 cells (P<0.05), and causes much less inhibition of EGF-stimulated cell proliferation in EGF receptor over-expressed RGM-1 cells than in RGM-1 cells (22% vs. 32% reduction). [2] Clopidogrel increases blood vessel number, reduces polymorphonuclear count and decreases attachment and bone loss, also decreases osteoclast number in rats submitted or not to periodontal repair. Clopidogrel decreases CXCL4, CXCL12 and PDGF content compared with saline-treated rats, without affecting CXCL5. [3]

In vivo Clopidogrel (2mg and 10mg/kg/day) significantly decreases ulcer-induced gastric epithelial cell proliferation and ulcer-stimulated expressions of EGF receptor and phosphorylated extracellular signal-regulated kinase (PERK) at the ulcer margin of rats. [2] Clopidogrel improves endothelial function and NO bioavailability in rats with congestive heart failure. Clopidogrel-treated Congestive heart failure (CHF) rat displays enhances phosphorylation of AKT and eNOS. [4] The clopidogrel/aspirin combination shows only additive-type effects on bleeding time prolongation induced by ear transection in the rabbit, therefore showing that combined inhibition of cyclooxygenase and ADP's effects provide a marked enhanced antithrombotic efficacy. [5]

Protocol

Solubility (25°C)

In vitro DMSO 83 mg/mL (197.66 mM)
Water 78 mg/mL (185.75 mM)
Ethanol 46 mg/mL (109.54 mM)

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 419.9
Formula

C16H16ClNO2S.H2SO4

CAS No. 120202-66-6
Storage powder
in solvent
Synonyms SR-25990C

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT03806894 Not yet recruiting Diagnostic Test: Quantification of platelet aggregation Clopidogrel Poor Metabolism of|Ischemic Stroke Ziv Hospital October 2019 --
NCT03188705 Not yet recruiting Drug: Clopidogrel|Drug: Aspirin Heart Diseases|Coronary Disease|Coronary Artery Disease|Cardiovascular Diseases|Myocardial Ischemia|Artery Occlusion|Aspirin Sensitivity|Clopidogrel Poor Metabolism of|Platelet Dysfunction|Platelet Thrombus University of Maryland Baltimore September 1 2019 Phase 4
NCT02302508 Withdrawn Drug: Clopidogrel Prasugrel Ticagrelor Diabetes Centre hospitalier de l''Université de Montréal (CHUM)|Centre de Recherche du Centre Hospitalier de l''Université de Montréal September 1 2019 Phase 4
NCT03774394 Recruiting Drug: Clopidogrel|Drug: Clopidogrel active metabolite Chronic Kidney Disease (CKD)|Type 2 Diabetes Mellitus (T2DM)|Coronary Artery Disease (CAD) University of Florida August 22 2019 Phase 4
NCT04088682 Recruiting Behavioral: Quality improvement strategies and tools ST Elevation Myocardial Infarction China National Center for Cardiovascular Diseases July 15 2018 --

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

P2 Receptor Signaling Pathway Map

Related P2 Receptor Products

Tags: buy Clopidogrel Bisulfate | Clopidogrel Bisulfate ic50 | Clopidogrel Bisulfate price | Clopidogrel Bisulfate cost | Clopidogrel Bisulfate solubility dmso | Clopidogrel Bisulfate purchase | Clopidogrel Bisulfate manufacturer | Clopidogrel Bisulfate research buy | Clopidogrel Bisulfate order | Clopidogrel Bisulfate mouse | Clopidogrel Bisulfate chemical structure | Clopidogrel Bisulfate mw | Clopidogrel Bisulfate molecular weight | Clopidogrel Bisulfate datasheet | Clopidogrel Bisulfate supplier | Clopidogrel Bisulfate in vitro | Clopidogrel Bisulfate cell line | Clopidogrel Bisulfate concentration | Clopidogrel Bisulfate nmr
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID